Summary
Greater Manchester hospitals are rolling out Prostate Intelligence (Pi™), an AI tool that analyses MRI scans to identify men with prostate cancer who need urgent treatment first. The pilot, led by Greater Manchester Cancer Alliance, supports radiologists by flagging the most suspicious cases, allowing faster diagnosis and prioritisation of patients requiring immediate intervention.
Prostate cancer affects 1 in 8 men in the UK and is the most common cancer in males, yet around half of cases are diagnosed at a late stage after spread has occurred. The AI system aims to improve both speed and accuracy of diagnosis when men with suspected symptoms or raised PSA blood test results are referred for MRI scanning.
The pilot is part of a wider roll-out across the North West, with parallel programmes running in Yorkshire, East England and the South West. A service evaluation will be undertaken to assess the impact on diagnosis rates and patient outcomes, with clinical oversight maintained throughout.
Read the full story at Prolific North
This is a summary written for the Manchester Business Services register. The full article belongs to Prolific North — read it at source.
Common questions
- What is this article about?
- Hospitals across Greater Manchester have introduced an AI system to analyse MRI scans and identify prostate cancer cases requiring urgent treatment as part of a pilot by Greater Manchester Cancer Alliance. The technology, developed by Lucida Medical, aims to help radiologists prioritise suspicious cases and reduce diagnostic delays.
- When was this published?
- This article was published on 7 August 2026.
- Who published this article?
- This article was published by Prolific North.